TomoWave Medical Group is the leading developer of 3D functional optoacoustic tomography and molecular imaging systems combined with premium high-end ultrasound. Founded by the original inventor of this proprietary technology, Dr. Alexander Oraevsky, TomoWave developed its medical imaging systems based on $20 M in the US government grants awarded to the Founder and CEO. This Series-A round of equity investment will enable increase in the annual sales revenue from $1.5M in 2024 to $75M by 2027 due to rapid DeNovo regulatory approval in the two largest global markets of USA and China.
Ø TomoWave has attained a team of star business advisors and consultants and established strategic relationships with a larger company, the leader in the ultrasound research.
Ø TomoWave developed a portfolio of imaging systems designed to assist healthcare professionals in the early detection of cancer and vascular diseases, to provide image guidance for therapeutic and surgical interventions.
Ø TomoWave is asking for up to $10M (3 annual tranches are acceptable) in Series-A equity investment to enable continuous growth and profitability through rapidly increasing sales.
Ø Driven by a cutting-edge R&D, a portfolio of valuable patents, collaborative partnerships with leading industrial, clinical and academic institutions, and a team of seasoned experts in the field of medical technology, TomoWave Business Plan fits well in your area of investment expertise and promises to bring significant ROI faster than a typical medical device technology.
Ready to Ask For Funding for your company?
Post a Funding Request